Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Acutely ill immobilized patients are at a high risk for thromboembolic events including deep
venous thrombosis or pulmonary embolism. Unfractionated heparin (UFH) and low molecular
weight heparins (LMWH) are thought to be effective in preventing thromboembolic events. This
study is designed to provide efficacy and safety data for thromboprophylaxis with the LMWH
certoparin in comparison to thromboprophylaxis with UFH in acutely ill non-surgical patients.